The cause

Support the funding of cancer research

8th EDITION OF THE MASKED EVENING : FRAGRANCES OF THE LEVANT

For a special edition, the Montreal Cancer Institute’s Masked Evening took place on November 16 at Théâtre Cartier in the form of a banquet. The 8th edition raised over $172,000. Thank you to all the guests and partners of the event.

The proceeds from the 2024 Masked Evening will help fund the enhancement of a critical piece of equipment used to study cancer and test new treatments: the Incucyte platform. This advanced system of microscopes allows for real-time observation of living cells. With the integration of artificial intelligence, among other upgrades, the platform’s cell study capacity will be doubled, and advanced analytical tools will be added. Practically speaking, this will enable testing of numerous drugs on cancer cells collected from patients to identify the most effective treatments.

Thanks to our 2024 partners!

Scene Presenter

GOLD Partner

BRONZE Partner

Thank you to our product and service partners:

  • Agence Tocade
  • Daou
  • DJ Yo-C
  • Expert’Ease
  • Encan Eclipse
  • Four Seasons
  • L’effet-mer
  • Le Pois Penché
  • Los Olas Traiteur
  • Luz Ambiance
  • Patisserie Mahrouse
  • Photobooth-Fun
  • RéZin
  • Serres Cléroux
  • Sylvain Caron Production
  • Théâtre Cartier

History

Since 2015, more than $ 796,000 has been invested in research projects and the purchase of specialized equipment.

Review of funded projects:

  • 2023 : Proceeds went to support a research program in artificial intelligence to improve the care of cancer patients. They enabled the purchase of servers to help predict cancer response, personalize treatments and reduce side effects, in ENT, lung, digestive, prostate and brain cancers.
  • 2022 : Funds were raised for brain cancer research.
  • 2019 : Funds were raised for research on glioblastoma, a malignant brain tumor.
  • 2018: The establishment of a new research program that examines the importance of interactions between lymphoma and the environment present in the lymph nodes on the function of immune cells, in relation to the response to treatment. It will support the development of new treatments for lymphoma.
  • 2017: The acquisition of a device that allows you to view cells cultured in the laboratory in real time and to monitor their behavior in the face of new treatments.
  • 2016: A clinical and basic research project that revolves around a cohort of adults in remission struggling with side effects following treatment for cancer received at a young age.
  • 2015: Purchase of advanced cancer tumor analysis equipment to refine diagnosis and predict response to treatment.

2024 Campaign cabinet

  • Benoit Arcand
  • Clare Lord
  • Claudia Pharand
  • Cynthia Baroud
  • Geneviève Pagé
  • Helga Dathe
  • Houda Bahig
  • Isabelle Rochefort
  • Jean-Paul Bahary
  • Marie-Andrée Côté
  • Marie-Ève Boileau-Loiselle
  • Nadia Paquet
  • Pierre Nollet
  • Shirley Byrns
  • Suhad Tantawi